Merck has announced a collaboration with analytics company Elsevier that will see Merck's products added to Reaxys, Elsevier's chemistry database.
Through this agreement, researchers and chemists who use Reaxys will be able to access an additional 43,000 Merck life science compounds and chemicals, with data provided directly from the supplier.
“Merck has agreed to add its products into Reaxys, Elsevier's chemistry database.“
This means users will have immediate access to Merck's product availability, allowing those working in pharmaceutical drug discovery, chemical research and other areas to take advantage of a more efficient purchasing process.
Customers can also quickly compare the cost of purchasing a compound against producing it internally, meaning they will be able to make better and timelier decisions about the use of resources.
Reaxys includes data on 105 million organic, inorganic and organometallic compounds, 42 million chemical reactions, 500 million published experimental facts, 16,000 chemistry related periodicals and six indexing sources in total.
Udit Batra, member of the Merck executive board and chief executive officer for life sciences, said: "Together, we're giving customers peace of mind about the quality of the products in development, which is important in such a competitive industry."
With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Science